CVS 2012 Annual Report Download - page 57

Download and view the complete annual report

Please find page 57 of the 2012 CVS annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 92

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92

CVS CAREMARK 2012 ANNUAL REPORT
55
Consolidated Statements of Shareholders’ Equity
Shares Dollars
Year Ended December 31, Year Ended December 31,
In millions 2012 2011 2010 2012 2011 2010
Common stock:
Beginning of year 1,640 1,624 1,612 $ 16 $ 16 $ 16
Stock options exercised and issuance
of stock awards 27 16 12 1 — —
End of year 1,667 1,640 1,624 $ 17 $ 16 $ 16
Treasury stock:
Beginning of year (340) (259) (219) $ (11,953) $ (9,030) $ (7,610)
Purchase of treasury shares (95) (84) (42) (4,330) (3,001) (1,500)
Employee stock purchase plan issuances 1 3 2 47 78 80
Transfer of shares from shares held in trust (1) — — (34) — —
End of year (435) (340) (259) $ (16,270) $ (11,953) $ (9,030)
Shares held in trust:
Beginning of year (2) (2) (2) $ (56) $ (56) $ (56)
Transfer of shares to treasury stock 1 — — 25 — —
End of year (1) (2) (2) $ (31) $ (56) $ (56)
Capital surplus:
Beginning of year $ 28,126 $ 27,610 $ 27,198
Stock option activity and stock awards 955 495 384
Tax benefit on stock options and stock awards 28 21 28
Transfer of shares held in trust to
treasury stock 9 — —
Purchase of noncontrolling interest
in subsidiary 2 — —
End of year $ 29,120 $ 28,126 $ 27,610
Retained earnings:
Beginning of year $ 22,090 $ 19,303 $ 16,355
Changes in inventory accounting
principles (Note 2) (89) — —
Net income attributable to CVS Caremark 3,877 3,461 3,427
Common stock dividends (829) (674) (479)
End of year $ 25,049 $ 22,090 $ 19,303
Accumulated other comprehensive loss:
Beginning of year $ (172) $ (143) $ (135)
Net cash flow hedges, net of income tax 3 (9) (1)
Pension liability adjustment, net of income tax (12) (20) (7)
End of year $ (181) $ (172) $ (143)
Total shareholders’ equity $ 37,704 $ 38,051 $ 37,700
See accompanying notes to consolidated financial statements.